Benazecare is indicated for the treatment of congestive heart failure in dogs and the treatment of chronic renal insufficiency (CRI) in cats.
After being given orally benazepril is rapidly absorbed and converted into Benazeprilat, a highly specific and potent inhibitor of angiotensin converting enzyme (ACE). In dogs with heart failure, benazeprilat lowers the blood pressure and volume loading effect on the heart. In cats with renal insufficiency, benazeprilat reduces the protein loss in urine.
Benazepril has been shown to increase the appetite, quality of life and the survival time of cats particularly in advanced disease.
For oral use only in both dogs and cats, Benazecare should be given orally once daily with or without food. The duration of treatment is unlimited.
- Do not use in any dog that has evidence of cardiac output failure.
- Do not use in pregnant or nursing bitches or queens, or in bitches or queens intended for breeding.
- Pregnant women should take special care to avoid accidental exposure.
Available in 5mg and 20mg tablets.
Legal Category: POM-V
To find details on all veterinary medicinal products currently authorised in the UK, please see the VMD's Product Information Database.
IMPORTANT LEGAL INFORMATION: this is a Veterinary Prescription Only Medicine (POM-V), which can only be prescribed by a veterinary surgeon, but may be dispensed by another veterinary surgeon or pharmacist.
You can download a Vetscriptions Prescription form here.